Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.

Mulder FI, van Es N, Kraaijpoel N, Di Nisio M, Carrier M, Duggal A, Gaddh M, Garcia D, Grosso MA, Kakkar AK, Mercuri MF, Middeldorp S, Royle G, Segers A, Shivakumar S, Verhamme P, Wang T, Weitz JI, Zhang G, Büller HR, Raskob G.

Thromb Res. 2020 Jan;185:13-19. doi: 10.1016/j.thromres.2019.11.007. Epub 2019 Nov 9.

PMID:
31733403
2.

Clinical implications of incidental venous thromboembolism in cancer patients.

Mulder FI, Di Nisio M, Ay C, Carrier M, Bosch FTM, Segers A, Kraaijpoel N, Grosso MA, Zhang G, Verhamme P, Wang TF, Weitz JI, Middeldorp S, Raskob G, Beenen LFM, Büller HR, van Es N.

Eur Respir J. 2019 Nov 14. pii: 1901697. doi: 10.1183/13993003.01697-2019. [Epub ahead of print]

PMID:
31727694
3.

The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism.

Mulder FI, Kraaijpoel N, Di Nisio M, Meyer G, Mahé I, Muñoz A, Bertoletti L, Biosca M, Maraveyas A, Büller HR, van Es N.

Thromb Res. 2019 Sep;181:59-63. doi: 10.1016/j.thromres.2019.07.005. Epub 2019 Jul 11.

PMID:
31352267
4.

Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.

Di Nisio M, van Es N, Carrier M, Wang TF, Garcia D, Segers A, Weitz J, Buller H, Raskob G.

J Thromb Haemost. 2019 Nov;17(11):1866-1874. doi: 10.1111/jth.14561. Epub 2019 Jul 25.

PMID:
31271705
5.

Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study.

Kraaijpoel N, Bleker SM, Meyer G, Mahé I, Muñoz A, Bertoletti L, Bartels-Rutten A, Beyer-Westendorf J, Porreca E, Boulon C, van Es N, Iosub DI, Couturaud F, Biosca M, Lerede T, Lacroix P, Maraveyas A, Aggarwal A, Girard P, Büller HR, Di Nisio M; UPE investigators.

J Clin Oncol. 2019 Jul 10;37(20):1713-1720. doi: 10.1200/JCO.18.01977. Epub 2019 May 22.

PMID:
31116676
6.

Ruling out pulmonary embolism across different subgroups of patients and healthcare settings: protocol for a systematic review and individual patient data meta-analysis (IPDMA).

Geersing GJ, Kraaijpoel N, Büller HR, van Doorn S, van Es N, Le Gal G, Huisman MV, Kearon C, Kline JA, Moons KGM, Miniati M, Righini M, Roy PM, van der Wall SJ, Wells PS, Klok FA.

Diagn Progn Res. 2018 Jul 2;2:10. doi: 10.1186/s41512-018-0032-7. eCollection 2018.

7.

Follow-up to comment on "Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: Systematic Review and Meta-Analysis".

Elsebaie MAT, Van Es N, Langston A, Büller HR, Gaddh M.

J Thromb Haemost. 2019 Jun;17(6):1007-1009. doi: 10.1111/jth.14453. No abstract available.

PMID:
31009157
8.

Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients.

Di Nisio M, van Es N, Rotunno L, Anzoletti N, Falcone L, De Tursi M, Natoli C, Tinari N, Cavallo I, Valeriani E, Candeloro M, Guglielmi MD, Rutjes AWS, Porreca E.

J Thromb Thrombolysis. 2019 Jul;48(1):125-133. doi: 10.1007/s11239-019-01845-6.

PMID:
30919253
9.

Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis.

Jara-Palomares L, van Es N, Praena-Fernandez JM, Le Gal G, Otten HM, Robin P, Piccioli A, Lecumberri R, Religa P, Rieu V, Rondina M, Beckers M, Prandoni P, Salaun PY, Di Nisio M, Bossuyt PM, Kraaijpoel N, Büller HR, Carrier M.

Thromb Res. 2019 Apr;176:79-84. doi: 10.1016/j.thromres.2019.02.011. Epub 2019 Feb 13.

PMID:
30780008
10.

Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.

Elsebaie MAT, van Es N, Langston A, Büller HR, Gaddh M.

J Thromb Haemost. 2019 Apr;17(4):645-656. doi: 10.1111/jth.14398. Epub 2019 Feb 25.

PMID:
30690830
11.

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.

Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N, Smit K, Büller HR, van Es N; CAT-prediction collaborators.

Haematologica. 2019 Jun;104(6):1277-1287. doi: 10.3324/haematol.2018.209114. Epub 2019 Jan 3.

12.

Extended treatment of venous thromboembolism: a systematic review and network meta-analysis.

Wang KL, van Es N, Cameron C, Castellucci LA, Büller HR, Carrier M.

Heart. 2019 Apr;105(7):545-552. doi: 10.1136/heartjnl-2018-313617. Epub 2018 Oct 16.

PMID:
30327391
13.

Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism.

Robin P, Otten HM, Delluc A, van Es N, Carrier M, Salaün PY, Le Gal G.

Thromb Res. 2018 Nov;171:92-96. doi: 10.1016/j.thromres.2018.09.055. Epub 2018 Sep 23.

PMID:
30268858
14.

Direct oral anticoagulants in patients with liver cirrhosis: A systematic review.

Hoolwerf EW, Kraaijpoel N, Büller HR, van Es N.

Thromb Res. 2018 Oct;170:102-108. doi: 10.1016/j.thromres.2018.08.011. Epub 2018 Aug 17.

PMID:
30153564
15.

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.

Kraaijpoel N, Di Nisio M, Mulder FI, van Es N, Beyer-Westendorf J, Carrier M, Garcia D, Grosso M, Kakkar AK, Mercuri MF, Middeldorp S, Hernandez CR, Santamaria A, Schwocho L, Segers A, Verhamme P, Wang TF, Weitz JI, Zhang G, Zwicker JI, Büller HR, Raskob GE.

Thromb Haemost. 2018 Aug;118(8):1439-1449. doi: 10.1055/s-0038-1667001. Epub 2018 Jul 30.

PMID:
30060256
16.

A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.

Pabinger I, van Es N, Heinze G, Posch F, Riedl J, Reitter EM, Di Nisio M, Cesarman-Maus G, Kraaijpoel N, Zielinski CC, Büller HR, Ay C.

Lancet Haematol. 2018 Jul;5(7):e289-e298. doi: 10.1016/S2352-3026(18)30063-2. Epub 2018 Jun 7. Erratum in: Lancet Haematol. 2018 Jun 15;:.

17.

Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.

Kraaijpoel N, van Es N, Raskob GE, Büller HR, Carrier M, Zhang G, Lin M, Grosso MA, Di Nisio M.

Thromb Haemost. 2018 Jul;118(7):1270-1278. doi: 10.1055/s-0038-1649523. Epub 2018 Jun 4.

PMID:
29864787
18.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: comment.

Kraaijpoel N, Toorop MMA, Bossuyt PM, Klok FA, Büller HR, van Es N.

J Thromb Haemost. 2018 Jul;16(7):1445-1448. doi: 10.1111/jth.14133. Epub 2018 Jun 12. No abstract available.

PMID:
29733495
19.

Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.

van Es N, Hisada Y, Di Nisio M, Cesarman G, Kleinjan A, Mahé I, Otten HM, Kamphuisen PW, Berckmans RJ, Büller HR, Mackman N, Nieuwland R.

Thromb Res. 2018 Jun;166:54-59. doi: 10.1016/j.thromres.2018.04.009. Epub 2018 Apr 10.

PMID:
29656167
20.

Reporting bias in imaging: higher accuracy is linked to faster publication.

Sharifabadi AD, Korevaar DA, McGrath TA, van Es N, Frank RA, Cherpak L, Dang W, Salameh JP, Nguyen F, Stanley C, McInnes MDF.

Eur Radiol. 2018 Sep;28(9):3632-3639. doi: 10.1007/s00330-018-5354-x. Epub 2018 Mar 21.

PMID:
29564596
21.

Sex-specific performance of pre-imaging diagnostic algorithms for pulmonary embolism.

van Mens TE, van der Pol LM, van Es N, Bistervels IM, Mairuhu ATA, van der Hulle T, Klok FA, Huisman MV, Middeldorp S.

J Thromb Haemost. 2018 May;16(5):858-865. doi: 10.1111/jth.13984. Epub 2018 Mar 22.

PMID:
29460484
22.

Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study.

van Es N, Louzada M, Carrier M, Tagalakis V, Gross PL, Shivakumar S, Rodger MA, Wells PS.

Thromb Res. 2018 Mar;163:41-46. doi: 10.1016/j.thromres.2018.01.009. Epub 2018 Jan 9.

PMID:
29353682
23.

Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent.

Brekelmans MPA, Büller HR, Mercuri MF, Ageno W, Chen CZ, Cohen AT, van Es N, Grosso MA, Medina AP, Raskob G, Segers A, Vanassche T, Verhamme P, Wells PS, Zhang G, Weitz JI.

TH Open. 2018 Jan 8;2(1):e1-e7. doi: 10.1055/s-0037-1615251. eCollection 2018 Jan.

24.

Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.

Kraaijpoel N, van Es N, Bleker SM, Brekelmans MPA, Eerenberg ES, Middeldorp S, Cohen AT, Raskob GE, Büller HR.

Thromb Haemost. 2018 Jan;118(1):174-181. doi: 10.1160/TH17-04-0274. Epub 2018 Jan 5.

PMID:
29304537
25.

Genes associated with venous thromboembolism in colorectal cancer patients.

Ünlü B, van Es N, Arindrarto W, Kiełbasa SM, Mei H, Westerga J, Middeldorp S, Kuppen PJK, Otten JMMB, Cannegieter S, Versteeg HH.

J Thromb Haemost. 2018 Feb;16(2):293-302. doi: 10.1111/jth.13926. Epub 2018 Jan 15.

PMID:
29247594
26.

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.

Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators.

N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12.

27.

Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials.

Di Minno MND, Ageno W, Lupoli R, Conte G, van Es N, Buller HR, Dentali F.

Eur Respir J. 2017 Sep 27;50(3). pii: 1701097. doi: 10.1183/13993003.01097-2017. Print 2017 Sep. No abstract available.

28.

Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient Data.

van Es N, Le Gal G, Otten HM, Robin P, Piccioli A, Lecumberri R, Jara-Palomares L, Religa P, Rieu V, Rondina M, Beckers MM, Prandoni P, Salaun PY, Di Nisio M, Bossuyt PM, Büller HR, Carrier M.

Ann Intern Med. 2017 Sep 19;167(6):410-417. doi: 10.7326/M17-0868. Epub 2017 Aug 22. Review.

PMID:
28828492
29.

Overinterpretation of Research Findings: Evidence of "Spin" in Systematic Reviews of Diagnostic Accuracy Studies.

McGrath TA, McInnes MDF, van Es N, Leeflang MMG, Korevaar DA, Bossuyt PMM.

Clin Chem. 2017 Aug;63(8):1353-1362. doi: 10.1373/clinchem.2017.271544. Epub 2017 Jun 12. Review.

30.

Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis.

van Es N, Le Gal G, Otten HM, Robin P, Piccioli A, Lécumberri R, Jara-Palomares L, Religa P, Rieu V, Rondina MT, Beckers MM, Prandoni P, Salaun PY, Nisio MD, Bossuyt PM, Büller HR, Carrier M.

BMJ Open. 2017 Jun 10;7(6):e015562. doi: 10.1136/bmjopen-2016-015562. Erratum in: BMJ Open. 2017 Aug 11;7(8):e015562corr1.

31.

The diagnostic management of upper extremity deep vein thrombosis: A review of the literature.

Kraaijpoel N, van Es N, Porreca E, Büller HR, Di Nisio M.

Thromb Res. 2017 Aug;156:54-59. doi: 10.1016/j.thromres.2017.05.035. Epub 2017 Jun 1. Review.

PMID:
28586697
32.

Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis.

van der Hulle T, van Es N, den Exter PL, van Es J, Mos ICM, Douma RA, Kruip MJHA, Hovens MMC, Ten Wolde M, Nijkeuter M, Ten Cate H, Kamphuisen PW, Büller HR, Huisman MV, Klok FA.

Thromb Haemost. 2017 Jul 26;117(8):1622-1629. doi: 10.1160/TH17-02-0076. Epub 2017 Jun 1.

PMID:
28569924
33.

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study.

van Es N, Di Nisio M, Cesarman G, Kleinjan A, Otten HM, Mahé I, Wilts IT, Twint DC, Porreca E, Arrieta O, Stépanian A, Smit K, De Tursi M, Bleker SM, Bossuyt PM, Nieuwland R, Kamphuisen PW, Büller HR.

Haematologica. 2017 Sep;102(9):1494-1501. doi: 10.3324/haematol.2017.169060. Epub 2017 May 26.

34.

D-dimer Interval Likelihood Ratios for Pulmonary Embolism.

Kohn MA, Klok FA, van Es N.

Acad Emerg Med. 2017 Jul;24(7):832-837. doi: 10.1111/acem.13191. Epub 2017 Jun 14. Review.

35.

Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.

van Es N, Wells PS, Carrier M.

Thromb Res. 2017 Apr;152:52-60. doi: 10.1016/j.thromres.2017.02.016. Epub 2017 Feb 20. Review.

PMID:
28237891
36.

The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis.

van Es N, Kraaijpoel N, Klok FA, Huisman MV, Den Exter PL, Mos IC, Galipienzo J, Büller HR, Bossuyt PM.

J Thromb Haemost. 2017 Apr;15(4):678-684. doi: 10.1111/jth.13630. Epub 2017 Feb 16.

37.

The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.

van Es N, Franke VF, Middeldorp S, Wilmink JW, Büller HR.

Thromb Res. 2017 Feb;150:30-32. doi: 10.1016/j.thromres.2016.12.013. Epub 2016 Dec 16.

PMID:
28002757
38.

Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism?

van Es N, van der Hulle T, Büller HR, Klok FA, Huisman MV, Galipienzo J, Di Nisio M.

J Thromb Haemost. 2017 Feb;15(2):323-328. doi: 10.1111/jth.13574. Epub 2016 Dec 24.

39.

A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients.

van Es N, Bleker SM, Di Nisio M, Kleinjan A, Beyer-Westendorf J, Camporese G, Kamphuisen PW, Büller HR, Bossuyt PM; ARMOUR study investigators.

Thromb Res. 2016 Dec;148:59-62. doi: 10.1016/j.thromres.2016.10.019. Epub 2016 Oct 24.

PMID:
27815967
40.

Improving the diagnostic management of upper extremity deep vein thrombosis.

van Es N, Bleker SM, Di Nisio M, Kleinjan A, Beyer-Westendorf J, Camporese G, Aggarwal A, Verhamme P, Righini M, Büller HR, Bossuyt PM.

J Thromb Haemost. 2017 Jan;15(1):66-73. doi: 10.1111/jth.13536. Epub 2016 Nov 28.

41.

Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots.

Bleker SM, Beenen LF, Di Nisio M, van Es N, Büller HR, Kraaijpoel N, Rutten A.

Thromb Res. 2016 Nov;147:46-51. doi: 10.1016/j.thromres.2016.09.015. Epub 2016 Sep 17.

PMID:
27669127
42.

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.

Raskob GE, van Es N, Segers A, Angchaisuksiri P, Oh D, Boda Z, Lyons RM, Meijer K, Gudz I, Weitz JI, Zhang G, Lanz H, Mercuri MF, Büller HR; Hokusai-VTE investigators.

Lancet Haematol. 2016 Aug;3(8):e379-87. doi: 10.1016/S2352-3026(16)30057-6. Epub 2016 Jul 1.

PMID:
27476789
43.

Deep vein thrombosis and pulmonary embolism.

Di Nisio M, van Es N, Büller HR.

Lancet. 2016 Dec 17;388(10063):3060-3073. doi: 10.1016/S0140-6736(16)30514-1. Epub 2016 Jun 30. Review.

PMID:
27375038
44.

Dermoscopy of glomus tumor: More white than pink.

Mutsaers ER, Genders R, van Es N, Kukutsch N.

J Am Acad Dermatol. 2016 Jul;75(1):e17-8. doi: 10.1016/j.jaad.2016.01.049. No abstract available.

PMID:
27317535
45.

Time to publication among completed diagnostic accuracy studies: associated with reported accuracy estimates.

Korevaar DA, van Es N, Zwinderman AH, Cohen JF, Bossuyt PM.

BMC Med Res Methodol. 2016 Jun 6;16:68. doi: 10.1186/s12874-016-0177-4.

46.

Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolism: A Systematic Review and Individual-Patient Data Meta-analysis.

van Es N, van der Hulle T, van Es J, den Exter PL, Douma RA, Goekoop RJ, Mos IC, Galipienzo J, Kamphuisen PW, Huisman MV, Klok FA, Büller HR, Bossuyt PM.

Ann Intern Med. 2016 Aug 16;165(4):253-61. doi: 10.7326/M16-0031. Epub 2016 May 17. Review.

PMID:
27182696
47.

PO-07 - Excluding pulmonary embolism in cancer patients using the Wells rule and age-adjusted D-dimer testing: an individual patient data meta-analysis.

van Es N, van der Hulle T, van Es J, den Exter PL, Douma RA, Goekoop RJ, Mos IC, Garcia JG, Kamphuisen PW, Huisman MV, Klok FA, Büller HR, Bossuyt PM.

Thromb Res. 2016 Apr;140 Suppl 1:S179. doi: 10.1016/S0049-3848(16)30140-2. Epub 2016 Apr 8.

PMID:
27161697
48.

Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol.

Schünemann HJ, Ventresca M, Crowther M, Briel M, Zhou Q, Garcia D, Lyman G, Noble S, Macbeth F, Griffiths G, DiNisio M, Iorio A, Beyene J, Mbuagbaw L, Neumann I, Van Es N, Brouwers M, Brozek J, Guyatt G, Levine M, Moll S, Santesso N, Streiff M, Baldeh T, Florez I, Gurunlu Alma O, Solh Z, Ageno W, Marcucci M, Bozas G, Zulian G, Maraveyas A, Lebeau B, Buller H, Evans J, McBane R, Bleker S, Pelzer U, Akl EA; IPDMA heparin use in cancer patients research group.

BMJ Open. 2016 Apr 29;6(4):e010569. doi: 10.1136/bmjopen-2015-010569. Review.

49.

Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review.

Bleker SM, van Es N, van Gils L, Daams JG, Kleinjan A, Büller HR, Di Nisio M.

Thromb Res. 2016 Apr;140 Suppl 1:S81-8. doi: 10.1016/S0049-3848(16)30104-9. Review.

PMID:
27067985
50.

Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis.

Bleker SM, van Es N, Kleinjan A, Büller HR, Kamphuisen PW, Aggarwal A, Beyer-Westendorf J, Camporese G, Cosmi B, Gary T, Ghirarduzzi A, Kaasjager K, Lerede T, Marschang P, Meijer K, Otten HM, Porreca E, Righini M, Verhamme P, van Wissen S, Di Nisio M.

J Thromb Haemost. 2016 May;14(5):973-81. doi: 10.1111/jth.13291. Epub 2016 Apr 4.

Supplemental Content

Loading ...
Support Center